SARS-CoV-2 JN.1 Variant - Rising Zoonotic Threats and Immune Evasion

The Omicron variant of COVID-19 has been a major topic of discussion since it first emerged, and now a new sub-variant, JN.1, is raising concerns due to its potential to infect animals and evade the immune system. This COVID-19 News report covers a study conducted by researchers from the Chinese Academy of Medical Sciences & Peking Union Medical College (CAMS & PUMC)- China that warns of the potential zoonotic threat that the JN.1 variant along with its many newer sub-lineages poses.


SARS-CoV-2 JN.1 Variant - Rising Zoonotic Threats and Immune Evasion
Image - AI Generated

What is the Omicron JN.1 Variant?
The JN.1 variant is a sub-variant of Omicron, one of the many variants of the SARS-CoV-2 virus that causes COVID-19. Omicron has been known for its high transmissibility and ability to evade immunity from previous infections and vaccinations. JN.1 stands out due to its enhanced potential to spread among different species, not just humans.
 
Why is JN.1 Important?
JN.1 is notable for its ability to infect a wide range of animals, not just humans. This ability increases the risk of reverse zoonosis, where the virus can be transmitted from humans to animals and then back to humans, potentially leading to new outbreaks. Understanding this variant is crucial for preventing future pandemics and controlling the spread of the virus.
 
Study Highlights
Researchers conducted a detailed study to understand the characteristics of JN.1 and compared it with other variants like XBB.1.16, EG.5.1, and BA.2.86. They used pseudoviruses to test the susceptibility of these variants to 27 different animal ACE2 receptors, which are proteins on the surface of cells that the virus uses to enter the cells.
 
Key Findings
-Broad Host Range: The study found that JN.1 has a broad host range, similar to the original Wuhan strain of the virus, but with higher potential for infecting various animals. This means that the virus can infect multiple species, making it more difficult to control and eradicate.
 
-Mutation Impact: A specific mutation, L455S, in the JN.1 variant's spike protein increases its ability to fuse with and infect cells, making it more infectious than some other variants. This mutation decreases the stability of the spike protein but enhances its ability to cause infections.
 
-Immune Evasion: The L455S mutation also helps the virus evade the immune system, meaning that people who have been vaccinated or previously infected might not be as protected against JN.1. This is concerning as it suggests that the current immunity in the population may not be sufficient to prevent infections with this variant.
 
-Animal Infections: The study revealed that animals like squirrels, mice, and civets are more susceptible to infection with JN.1 compared to the original virus. This raises concerns about these animals acting as reservoirs for the virus, potentially leading to new outbreaks in humans.
 
Virological Characteristics
The spike (S) protein of SARS-CoV-2 is responsible for virus entry into cells. The JN.1 variant has several mutations in this protein that affect its function. The L455S mutation, in particular, decreases the stability of the spike protein but makes it more fusogenic, meaning it can more easily merge with cell membranes and cause infections. This mutation also allows the virus to evade neutralizing antibodies generated by previous infections or vaccinations.
 
Implications for Public Health
The ability of JN.1 to infect a variety of animals and evade immunity highlights the need for continuous surveillance of both human and animal populations. Monitoring susceptible animal species is crucial to prevent potential outbreaks and manage the spread of the virus.
 
-Enhanced Surveillance: Increased monitoring of both humans and animals for signs of infection with JN.1 and other variants. This includes regular testing of animal populations, especially those known to be susceptible to the virus.
 
-Vaccine Updates: Including components of new variants like XBB in vaccine formulations to enhance protection. Current vaccines might need to be updated to include the spike proteins of emerging variants to ensure broad protection.
-Public Awareness: Educating the public about the potential risks and encouraging vaccination and other preventive measures. Public health campaigns should emphasize the importance of vaccination and other preventive measures such as wearing masks and maintaining social distancing.
 
How Does JN.1 Compare to Other Variants?
While JN.1 shares some characteristics with other Omicron variants, it has unique features that make it particularly concerning:
 
-Higher Infectivity: JN.1 shows higher infectivity in certain cells, meaning it can spread more easily. This increased infectivity is due to the L455S mutation, which enhances the virus's ability to fuse with and enter cells.
 
-Reduced Stability: The L455S mutation makes the virus less stable but more ready to infect, which can lead to more efficient transmission. This instability might make the virus more prone to mutations, potentially leading to the emergence of even more infectious or immune-evasive variants.
 
-Vaccine Challenges: Current vaccines may offer less protection against JN.1, but breakthrough infections with other variants could potentially boost immunity against it. This suggests that vaccine formulations may need to be updated to include the spike proteins of emerging variants.
 
Preventing Zoonotic Transmission
The study emphasizes the importance of preventing zoonotic transmission to control the spread of COVID-19. Here are some key strategies:
 
-Wildlife Surveillance: Regular monitoring of wildlife populations for signs of infection. This includes testing animals in zoos, wildlife sanctuaries, and natural habitats.
 
-Biosecurity Measures: Implementing biosecurity measures in farms and wildlife reserves to prevent the transmission of the virus between animals and humans. This includes measures such as disinfecting facilities, controlling animal movements, and using protective equipment.
-Research and Collaboration: Encouraging international collaboration and research on zoonotic diseases. Sharing data and resources between countries can help to quickly identify and respond to new threats.
 
Conclusion
The emergence of the JN.1 variant underscores the ongoing challenges in the fight against COVID-19. Its ability to infect a wide range of animals and evade the immune system makes it a significant concern. Continued research, surveillance, and public health measures are essential to manage and mitigate the risks associated with this and other emerging variants.
 
The study findings aim to provide a clear and accessible overview of the recent findings on the JN.1 variant, highlighting the importance of ongoing vigilance in the battle against COVID-19. By staying informed and taking proactive measures, we can help to prevent future outbreaks and protect public health.
 
The study findings were published on a preprint server and are currently being peer reviewed.
https://papers.ssrn.com/sol3/papers.cfm?abstract_id=4874431
 
For the latest COVID-19 News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/thailand-medical-researchers-find-that-up-to-22-67-percent-of-cats-tested-during-the-last-five-covid-19-waves-were-seropositive
 
https://www.thailandmedical.news/news/covid-19-news-worrisome-cryptic-sars-cov-2-lineage-identified-on-two-mink-farms-in-poland-that-are-capable-of-infecting-humans